2018


June: Lundbeck supports dementia research in Denmark

New network aims at improving the conditions for running clinical trials.

June: Lundbeck rated best in the world in regulatory affairs

A global survey of 70 pharmaceutical companies ranks Lundbeck as number one in the industry.

May: Lundbeck research enhances understanding of Alzheimer’s

Biological hypothesis behind our antibody treatment is confirmed in major step forward for the project.

April: Strong global recognition of Lundbeck’s reputation

In a worldwide survey, Lundbeck is ranked number 2 out of 46 pharma companies when it comes to our reputation among patient groups working with us.

March: Alzheimer’s researchers win world’s top brain research prize

The Brain Prize for 2018 is awarded to Bart De Strooper, Michel Goedert, Christian Haass and John Hardy for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease, with far-reaching implications for the development of new therapeutic interventions.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.